Precigen to Present at the JMP Securities Life Sciences Conference
Participants may access the live webcasts of the virtual events through
Cautionary Statement Regarding Forward-Looking Statements
Some of the statements made in this press release are forward-looking statements. These forward-looking statements are based upon Precigen's current expectations and projections about future events and generally relate to plans, objectives, and expectations for the development of Precigen's business, including the timing and progress of preclinical and clinical trials and discovery programs, and the promise of their portfolio of therapies. Although management believes that the plans and objectives reflected in or suggested by these forward-looking statements are reasonable, all forward-looking statements involve risks and uncertainties, including the possibility that the timeline for clinical trials might be impacted by the COVID-19 pandemic, and actual future results may be materially different from the plans, objectives and expectations expressed in this press release. Precigen has no obligation to provide any updates to these forward-looking statements even if its expectations change. All forward-looking statements are expressly qualified in their entirety by this cautionary statement. For further information on potential risks and uncertainties, and other important factors, any of which could cause Precigen's actual results to differ from those contained in the forward-looking statements, see the section entitled "Risk Factors" in Precigen's most recent Annual Report on Form 10-K and subsequent reports filed with the
For more information, contact:
Investor Contact: Vice President, Investor Relations Tel: +1 (301) 556-9850 |
Media Contact: |
View original content to download multimedia:http://www.prnewswire.com/news-releases/precigen-to-present-at-the-jmp-securities-life-sciences-conference-301310366.html
SOURCE